Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

The treatment was not recommended due to limited effectiveness and significant side effects.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Upadacitinib effectively treats psoriasis and lichen planus together.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

Infliximab may cause hair loss in Crohn's disease patients.

A new therapy for a skin blistering condition has not been developed yet.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

The rs1128977 gene variant may affect cholesterol and body measurements.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

PRP shows promise in healing but needs standardization for better results.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

RHUPUS should be considered in children with deforming arthritis.

JAK inhibitors show promise in treating difficult skin diseases.

A rare skin condition in a 17-year-old was diagnosed late, stressing the need for careful evaluation and genetic testing.

Etanercept effectively treated a severe skin condition when other treatments failed.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

PRP is a promising non-surgical option for skin and hair rejuvenation.